High expression of S100A4 facilitates NSCLC metastasis and immunosuppression via exosomes and the STAT3 pathway, which results in poor tumor differentiation, inhibition of autophagy, and worse prognosis (105, 106). Here, S100A4 is linked to neoplasm.